Name: THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC
Address: 40 WALL ST FL 24, NEW YORK, NY, 10005-1338, US
Telephone: (212) 227-7540

Our mission is to accelerate the discovery and development of faster-acting and affordable drugs to fight tuberculosis. Through innovative science and with partners around the world, we aim to ensure equitable access to faster, better tuberculosis cures that will advance global health and prosperity.
The Global Alliance for TB Drug Development (TB Alliance) is a not-for-profit, product development partnership accelerating the discovery and development of new tuberculosis (TB) drugs that will shorten treatment, be effective against susceptible and resistant strains, be compatible with antiretroviral therapies for those HIV-TB patients currently on such therapies, and improve treatment of latent infection.

TB is a contagious disease of global proportions, killing someone every twenty seconds. Today's TB drugs are more than 40 years old and must be taken for at least 6 months. Long, demanding treatment schedules prove too much for many patients, and the resulting erratic or inconsistent treatment breeds drug resistance. New drugs are desperately needed to save millions of lives needlessly lost to TB. Mounting resistance to today's drugs, including multi and extensively drug-resistant TB (MDR-TB and XDR-TB), coupled with a growing number of patients co-infected with TB and HIV, are making the pandemic more threatening and more deadly.

Working with public and private research laboratories worldwide, the TB Alliance is leading the advancement of the most comprehensive portfolio of TB drug candidates in history. The TB Alliance merges the best practices of the public and private sectors to meet this critical, global health need. As the leading developer of new TB drugs, we catalyze and convene ? bringing together the top minds of science and business to achieve our goals. Our value proposition and bottom line come down, simply, to the millions of tuberculosis patients worldwide who need us to succeed.

The TB Alliance is committed to ensuring that approved new regimens are affordable, adopted and available to those who need them. Recognizing that new, faster and better TB drugs will only be effective if they are affordable and available, the TB Alliance and its partners are working with global, regional, and national stakeholders to ensure regulatory approval, adoption by TB programs, and widespread availability of new drug regimens.

THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC

Business Info

Contact Business

Company Summary

Payments Accepted

Hours

Photos

Business Credit Report

Facebook

Twitter

Yelp

Customer Resources

Our Company

Our Network

Site Links